Results 141 to 150 of about 8,662,910 (358)
Stimuli‐responsive liposomes for drug delivery
, 2017 Y. Lee, David H. Thompson
openalex +2 more sources
MOF-Based Polymeric Nanocomposite Films as Potential Materials for Drug Delivery Devices in Ocular Therapeutics [PDF]
, 2020 Jesús Gándara-Loe +5 more
openalex +1 more source
Molecular Oncology, EarlyView.Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece +18 more
wiley +1 more source
New Challenges in the Narcotics World
EIRP Proceedings, 2011 The consumption of narcotics is one of the problems the international world is confronted withnowadays; its direct or indirect effects lead to the conclusion that it represents a worrying phenomenon meantto be taken into account by the international ...
Nicoleta-Elena Buzatu
doaj
Survivin and Aurora Kinase A control cell fate decisions during mitosis
Molecular Oncology, EarlyView.Aurora A interacts with survivin during mitosis and regulates its centromeric role. Loss of Aurora A activity mislocalises survivin, the CPC and BubR1, leading to disruption of the spindle checkpoint and triggering premature mitotic exit, which we refer to as ‘mitotic slippage’.
Hana Abdelkabir +2 more
wiley +1 more source
Swan's Song of the Publisher, Editor and Journalist of Elán [PDF]
Slovenska Literatura, 1999 Štefan Drug
doaj
Kinase Drug Discovery – What’s Next in the Field?
, 2012 Philip Cohen, Dario R. Alessi
openalex +1 more source
Molecular Oncology, EarlyView.CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir +12 more
wiley +1 more source
The spread of antimalarial drug resistance: A mathematical model with practical implications for ACT drug policies [PDF]
, 2008 Most malaria-endemic countries are implementing a change in antimalarial drug policy to artemisinin combination therapy (ACT). The impact of different drug choices and implementation strategies is uncertain.
Arjen Dondorp +5 more
core +1 more source